Shanghai No1 Pharmacy Co Ltd (600833) — Cash Flow-to-Debt Ratio
Shanghai No1 Pharmacy Co Ltd (600833) has a Cash Flow-to-Debt Ratio of -0.04x as of September 2025, meaning its operating cash flow of CN¥-30.88 Million could theoretically repay 0% of its total liabilities (CN¥860.40 Million) in one year. Explore Shanghai No1 Pharmacy Co Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai No1 Pharmacy Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Shanghai No1 Pharmacy Co Ltd across 28 annual periods. Also explore Shanghai No1 Pharmacy Co Ltd (600833) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Shanghai No1 Pharmacy Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Shanghai No1 Pharmacy Co Ltd. For market capitalisation and broader financial context, see Shanghai No1 Pharmacy Co Ltd market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | CN¥88.88 Million | CN¥850.46 Million | ▲ +78.1% |
| 2024 | 0.06x | CN¥49.03 Million | CN¥835.66 Million | ▼ -14.3% |
| 2023 | 0.07x | CN¥58.49 Million | CN¥854.72 Million | ▼ -44.1% |
| 2022 | 0.12x | CN¥132.31 Million | CN¥1.08 Billion | ▲ +86.4% |
| 2021 | 0.07x | CN¥36.56 Million | CN¥556.54 Million | ▼ -49.6% |
| 2020 | 0.13x | CN¥84.24 Million | CN¥646.94 Million | ▼ -39.7% |
| 2019 | 0.22x | CN¥104.60 Million | CN¥484.21 Million | ▲ +106.9% |
| 2018 | 0.10x | CN¥42.79 Million | CN¥409.90 Million | ▼ -63.3% |
| 2017 | 0.28x | CN¥120.07 Million | CN¥421.90 Million | ▲ +251.6% |
| 2016 | 0.08x | CN¥36.37 Million | CN¥449.29 Million | ▼ -25.9% |
| 2015 | 0.11x | CN¥48.82 Million | CN¥447.04 Million | ▲ +144.6% |
| 2014 | 0.04x | CN¥19.20 Million | CN¥430.01 Million | ▲ +160.2% |
| 2013 | 0.02x | CN¥6.52 Million | CN¥380.03 Million | ▼ -88.0% |
| 2012 | 0.14x | CN¥56.25 Million | CN¥392.43 Million | ▲ +112.0% |
| 2011 | 0.07x | CN¥24.67 Million | CN¥364.80 Million | ▼ -40.3% |
| 2010 | 0.11x | CN¥39.92 Million | CN¥352.30 Million | ▲ +33.7% |
| 2009 | 0.08x | CN¥27.06 Million | CN¥319.32 Million | ▲ +12.5% |
| 2008 | 0.08x | CN¥20.71 Million | CN¥274.95 Million | ▼ -44.8% |
| 2007 | 0.14x | CN¥41.35 Million | CN¥303.03 Million | ▼ -61.3% |
| 2006 | 0.35x | CN¥83.00 Million | CN¥235.38 Million | ▲ +175.3% |
| 2005 | 0.13x | CN¥14.21 Million | CN¥110.98 Million | ▲ +891.3% |
| 2004 | 0.01x | CN¥2.92 Million | CN¥226.40 Million | ▼ -85.5% |
| 2003 | 0.09x | CN¥26.30 Million | CN¥295.59 Million | ▲ +7.1% |
| 2002 | 0.08x | CN¥25.09 Million | CN¥302.08 Million | ▼ -53.4% |
| 2001 | 0.18x | CN¥56.49 Million | CN¥317.24 Million | ▲ +7696.3% |
| 2000 | 0.00x | CN¥2.01 Million | CN¥879.40 Million | ▲ +190.3% |
| 1999 | 0.00x | CN¥-2.59 Million | CN¥1.02 Billion | ▲ +98.3% |
| 1998 | -0.15x | CN¥-132.68 Million | CN¥886.85 Million | — |